Two-Year Survival Comparing Web-Based Symptom Monitoring vs Routine Surveillance Following Treatment for Lung Cancer.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 30667494.
- Also identified by DOI 10.1001/jama.2018.18085 and PMC identifier 6439676.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This study reports 2-year survival outcomes among patients with advanced nonprogressive stage IIA to IV lung cancer randomized to symptom monitoring during chemotherapy via web-based patient-reported outcomes vs standard scheduled imaging after treatment to detect symptomatic recurrence.
Medical subject headings
- Internet
- Lung Neoplasms
- Population Surveillance
- Self Report
- Symptom Assessment